About Tulip Diagnostics
Tulip Diagnostics is a company based in Panaji (India) founded in 1988 by Gihan Wijesinghe and Vinayak Naik was acquired by PerkinElmer in January 2017. The company has 1,416 employees as of April 04, 2024. Tulip Diagnostics has completed 1 acquisition, including Biosense. Tulip Diagnostics offers products and services including In-vitro Diagnostic Kits, Clinical Chemistry Reagents, Disinfectants, and Microbiology Range. Tulip Diagnostics operates in a competitive market with competitors including Roche, EKF, SonoSite, Cordant Health Solutions and NVision Imaging Technologies, among others.
- Headquarter Panaji, India
- Employees 1416 as on 04 Apr, 2024
- Founders Gihan Wijesinghe, Vinayak Naik
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tulip Diagnostics Private Limited
- Date of Incorporation 14 Dec, 1988
- Jurisdiction Tiswadi, Goa, India
-
Annual Revenue
$63.35 M (USD)-3.57as on Mar 31, 2023
-
Net Profit
$3.62 M (USD)148.07as on Mar 31, 2023
-
EBITDA
$8.96 M (USD)-13.15as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
1416
as on Apr 04, 2024
- Investments & Acquisitions
-
Acquired by
PerkinElmer
(Jan 03, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tulip Diagnostics
Tulip Diagnostics offers a comprehensive portfolio of products and services, including In-vitro Diagnostic Kits, Clinical Chemistry Reagents, Disinfectants, and Microbiology Range.
Kits for blood banking and serology testing in healthcare
Reagents for clinical chemistry analysis and controls
Products for hand and surface disinfection purposes
Items like culture media and stains for lab testing
Funding Insights of Tulip Diagnostics
Detailed funding history for Tulip Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Tulip Diagnostics
Tulip Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PerkinElmer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical instruments and supplies are manufactured and provided for healthcare.
|
Locked | Locked | Locked |
Investor details for Tulip Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tulip Diagnostics
Tulip Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Biosense.
Investment portfolio details for Tulip Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostic devices for multiple diseases are developed and provided.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Tulip Diagnostics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Tulip Diagnostics
Detailed financials for Tulip Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tulip Diagnostics Comparisons
Peer comparison for Tulip Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tulip Diagnostics
Tulip Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, EKF, SonoSite, Cordant Health Solutions and NVision Imaging Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| Locked | Locked | Locked |
Point-of-care and laboratory blood analyzers are developed by EKF.
|
|
| Locked | Locked | Locked |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| Locked | Locked | Locked |
Drug testing services are offered for clinical trials and workplaces.
|
|
| Locked | Locked | Locked |
Medical imaging is provided through quantum technologies.
|
|
| Locked | Locked | Locked |
Cloud based diagnostics platform for point of care diagnosing
|
Detailed competitors of Tulip Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tulip Diagnostics
Complete news archive for Tulip Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tulip Diagnostics
Tulip Diagnostics was founded in 1988.
Tulip Diagnostics is headquartered in Panaji, India. It is registered at Panaji, Goa, India.
Gihan Wijesinghe is the current CEO of Tulip Diagnostics. They have also founded this company.
As of Apr 04, 2024, the latest employee count at Tulip Diagnostics is 1,416.
Annual revenue of Tulip Diagnostics is $63.35M as on Mar 31, 2023.
Tulip Group offers in IVD kits and instruments for infectious diseases and clinical chemistry. The company offers a wide range of products that include Immunohaematology reagents, Immunology reagents, and Insight range (Hepatitis range, HBV range, and Drug of Abuse). The companys primary focus lies in immunohematology, hematology, rheumatology, infectious diseases, hemostasis, and instrumentation. The company has divisions under the names Orchid Biomedical Systems, Qualpro Diagnostics, Zephyr Biomedicals, BioShields, Microxpress, Viola Diagnostic Systems, and Coral Clinical Systems. Orchid Biomedical Systems, Qualpro Diagnostics, Zephyr Biomedicals focuses on rapid membrane ELISA based immunodiagnostic platforms along with chemiluminescence. Viola Diagnostic Systems deals with rapid immunoassays for parasitology range and infectious diseases. Coral Clinical Systems focuses on clinical biochemistry and instrumentation while its division BioShields deals with antiseptics and disinfectants for industrial, medical and domestic use. Microxpress focuses on dehydrated culture media, bases, supplements, reagent and test kits, sterile ready prepared plates, antimicrobial susceptibility discs, plant tissue culture media and chemicals for microbiology and mycobacteriology.
Tulip Diagnostics offers In-vitro Diagnostic Kits, Clinical Chemistry Reagents, Disinfectants, and Microbiology Range.
Tulip Diagnostics has made 1 acquisition, including Biosense.
Tulip Diagnostics has 1 investor. Key investors include PerkinElmer.